Friday, October 15, 2021
The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 12 major stocks, including Edwards Lifesciences Corp. (
EW
), DexCom, Inc. (
DXCM
), and Twitter, Inc. (
TWTR
). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see
all of today’s research reports here >>>
Shares of
Edwards Lifesciences
have outperformed the Zacks Medical Instruments industry in the year to date period (+19.1% vs. +6.5%). The Zacks analyst believes that the huge untapped potential in emerging markets will act as a positive catalyst for Edwards Lifesciences. The company is consolidating its foothold across all its operating businesses through strong pipeline development.
Strong adoption of the SAPIEN 3 Ultra platform and the PASCAL system across Europe is another positive. The solid demand for the company’s products used in high-risk surgeries is impressive too. Stiff competition in the THV business, however, continues to ail the company. Persistent forex woes are also a concern.
(You can
read the full research report on Edwards Lifesciences here >>>
)
DexCom
shares have gained +35.7% over the past year against the Zacks Medical Instruments industry’s gain of +6.6%. The Zacks analyst believes that a strong product portfolio, collaborative agreements with several companies and focus on international markets are key catalysts for growth.
DexCom’s Sensor and other revenue arm’s contribution, and domestic and international revenue growth were key catalysts in second-quarter 2021. The company made continued advancements with respect to key strategic objectives and ended the quarter with new patient additions. Intensifying competition, entry of new products, reimbursement risks, supply constraints and working capital problems are some of the major concerns.
(You can
read the full research report on DexCom here >>>
)
Shares of
Twitter
have lost -10.9% over the past six months against the Zacks Internet Software industry’s loss of -7%, however, things seem to be improving for the company. The Zacks analyst believes that the company’s initiatives to add features and focus on effectively tackling abuse issues are helping it expand its monetized user base.
Twitter is, however, suffering from stiff competition for ad dollars from the likes of Facebook and Google. Rising investments on international expansion, product innovation and marketing & sales are also expected to hurt profitability in the near term.
(You can
read the full research report on Twitter here >>>
)
Other noteworthy reports we are featuring today include Cigna Corp. (
CI
), T. Rowe Price Group, Inc. (
TROW
) and Restaurant Brands International Inc. (
QSR
).
Mark Vickery
Senior Editor
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly
Earnings Trends
and
Earnings Preview
reports. If you want an email notification each time Sheraz publishes a new article, please
click here>>>
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 7 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How to Profit from Trillions on Spending for Infrastructure >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report